Telora is a physician-signed clinical decision layer that licenses onto your telehealth platform through a single API. Patient intake comes in. A screened, safety-checked clinical package comes back before your provider opens the chart: a drafted SOAP note, ICD-10 and CPT codes, drug-interaction and contraindication checks, a formulary recommendation, and a patient message, in the patient's language — English or Spanish. Your licensed provider reviews, edits, and signs. It is decision support, not autonomous prescribing.
Your platform already works. Your providers are good, your intake flow is fine, your pharmacy rails are solid. The bottleneck is physics: one provider can safely handle about seven encounters an hour. Past that, corners get cut — notes get thin, red flags get missed, follow-ups slip. So you cap the volume, or you hire more providers, or you accept the risk.
visits completed per hour, per provider
The provider reads, adjusts, signs — under a minute. Same provider. Same license. Same standard of care — higher, actually, because nothing gets skipped when the system does it every single time. Measured in production at the practice where Telora was built.
Not a replacement for your platform. Your platform, with the governor removed.
Telora doesn't wait to be asked. It runs the moment intake arrives — in the background, headless, no clicks, no human input. There is no "run Telora" button, because nobody needs to press one.
By the time a provider glances at the queue, every patient is screened and sorted: green is prepared and ready to sign, yellow carries a caution for the provider to weigh, red has already been escalated — the emergency caught while the patient was still in the waiting room, not discovered mid-visit.
No chart had to be opened. The work was done before the question was asked.
Patients write in between visits: a side effect, a missed dose, a worry at eleven at night. Each one deserves the same care as the visit, and each one lands on a provider with a full queue. Telora Assist drafts the reply in seconds, written to your practice's message rules, with the reasoning and the references sitting right beside it.
The provider reads it, edits it in their own words, and sends it from your own system. Telora never messages a patient. It is a suggestion for a clinician, never an answer on its own.
Every draft lists the points it rests on: the protocol it follows, the practice rules it applies, and the warning signs it tells the patient to watch for. The provider checks the thinking in a glance instead of reverse-engineering a paragraph.
When a draft says something clinical, such as a side effect, a timing question, or an interaction, the Evidence panel lists the sources behind it, in the same format as Telora's SOAP-note evidence. The provider decides whether each claim stands. A shipping or billing question gets no citations, because it needs none.
Your practice's message rules are written into every draft: no doses in a patient message, emergency instructions first and in full, no promise of a prescription the provider hasn't made. If a message could be urgent, a red flag tells the provider to contact the patient now. The basis and the references sit beside the draft, so the review is fast and the provider stays the author.
The same clinician, sharper on the four-hundredth message than on the first. The decision, and every word that goes out, stays theirs.
For the operators and platforms who license Telora: this is provider capability as infrastructure. Your existing clinicians, producing measurably better encounters, powered by a physician-signed clinical engine working silently under every consult.
Structured intake, screened and organized before the chart is opened. Your providers spend their minutes on judgment, not reconstruction — which means more encounters per hour without cutting corners.
Telora catches emergencies, gates contraindications, and screens prescriptions — every rule authored and signed by a licensed physician who carries the liability. A chest-pain complaint on a routine visit is caught by code, not by luck. That is risk your platform no longer carries alone.
Documentation assembles itself around the clinician's judgment. Thoroughness stops costing time. The same roster delivers deeper, safer, faster care — and they stay. Retention is the quiet ROI.
Telora is calibrated for DTC telehealth brands running roughly 500 to 50,000 async encounters a month — pharma-heavy service lines especially. If you're somewhere between founding scrappy and true enterprise scale, you're exactly who this was built for.
Smaller and just getting started? You're welcome here too — Telora grows with you.
Commodity telehealth drove the price of a visit down and the value of a clinician with it. Telora inverts the equation: the provider is the product, and everything else exists to make them better.
What commodity telehealth pays a physician per visit — a race to the bottom that made speed the only metric.
Of healthcare revenue consumed by administration — the exact weight Telora removes from the clinical encounter.
Utilization on typical employer telehealth benefits. Patients can tell when the clinical experience is hollow, and they don't come back.
Clinical excellence has always been rationed by geography. Telora ends the rationing — the same quality of care in a small rural town as in a major city, delivered by clinicians who can now reach far beyond their own zip code.
No waiting rooms, physical or digital. The encounter arrives screened, organized, and safe — and the patient who has waited longest is finally first in line.
Not replaced. Not rushed. Amplified. Give a good clinician Telora and something happens that looks a lot like talent — faster reads, cleaner catches, total presence. It isn't talent. It's the weight coming off. Telora takes the providers you have and returns the providers you recruited.
Telora is onboarding founding platforms and provider groups now — operators who understand that clinical quality is the next competitive axis, and clinicians who want to practice the way they trained to. Request early access.